1620 Investment Advisors Inc. Acquires 149 Shares of Cardinal Health, Inc. (NYSE:CAH)

1620 Investment Advisors Inc. increased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 4.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,205 shares of the company’s stock after acquiring an additional 149 shares during the period. 1620 Investment Advisors Inc.’s holdings in Cardinal Health were worth $379,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in CAH. State Street Corp lifted its stake in shares of Cardinal Health by 4.6% in the third quarter. State Street Corp now owns 14,177,641 shares of the company’s stock worth $1,566,913,000 after buying an additional 627,253 shares in the last quarter. Raymond James Financial Inc. bought a new position in shares of Cardinal Health in the fourth quarter worth approximately $45,115,000. Two Sigma Advisers LP lifted its stake in shares of Cardinal Health by 47.9% in the third quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company’s stock worth $118,197,000 after buying an additional 346,362 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec lifted its stake in shares of Cardinal Health by 230.0% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 477,911 shares of the company’s stock worth $52,819,000 after buying an additional 333,095 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC raised its holdings in shares of Cardinal Health by 77.3% during the third quarter. Worldquant Millennium Advisors LLC now owns 593,007 shares of the company’s stock valued at $65,539,000 after purchasing an additional 258,541 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $133.02 on Friday. The firm has a fifty day moving average price of $127.15 and a 200 day moving average price of $119.87. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $133.77. The firm has a market cap of $32.13 billion, a price-to-earnings ratio of 24.82, a P/E/G ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.52%. Cardinal Health’s dividend payout ratio is 37.69%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CAH. Citigroup boosted their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a report on Friday, January 10th. Wells Fargo & Company boosted their price objective on shares of Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Bank of America raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $132.00 to $145.00 in a report on Monday, January 6th. Evercore ISI raised shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective for the company in a report on Tuesday, January 7th. Finally, TD Cowen raised shares of Cardinal Health from a “hold” rating to a “buy” rating and upped their target price for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health currently has an average rating of “Moderate Buy” and an average price target of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.